Bottom line
VHCIX vs JDOC: the short answer
VHCIX (Vanguard Health Care Index Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
But VHCIX is far broader, holding 407 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
VHCIX is cheaper at 0.09% vs 0.65% — a difference of $56 a year per $10,000 invested.
Over one year, JDOC returned +14.9% vs +2.7% for VHCIX (reporting dates differ).
Updated Nov 19, 2026
VHCIX vs JDOC side by side
| VHCIX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Vanguard | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.65% |
| Annual cost per $10k | $9 | $65 |
| 10-yr cost on $10k (prospectus) | $115 | $810 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +2.7% | +14.9% |
| 5-yr return (annualized) | +7.2% | — |
| 10-yr return (annualized) | +8.8% | — |
| Best quarter | +16.5% | +11.3% |
| Worst quarter | −13.1% | −11.9% |
| Net assets (fund) | $19.0B | $9.1M |
| Number of holdings | 407 | 61 |
| Portfolio turnover | 4% | 92% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHCIX | JDOC | Difference |
|---|---|---|---|
| 2024 | +2.7% | −0.6% | +3.3% |
Source: Fund prospectus bar charts
Holdings overlap
15 of VHCIX's top 25 holdings also appear in JDOC's top 25.
| Holding | VHCIX | JDOC |
|---|---|---|
| Eli Lilly & Co | 14.04% | 7.76% |
| Johnson & Johnson | 8.47% | 4.82% |
| AbbVie Inc | 6.09% | 7.85% |
| UnitedHealth Group Inc | 5.45% | 5.85% |
| Merck & Co Inc | 4.66% | 4.82% |
| Thermo Fisher Scientific Inc | 2.93% | 3.73% |
| Intuitive Surgical Inc | 2.38% | 1.93% |
| Abbott Laboratories | 2.35% | 3.11% |
| Bristol-Myers Squibb Co | 1.84% | 3.57% |
| Danaher Corp | 1.84% | 2.16% |
| CVS Health Corp | 1.83% | 2.83% |
| Stryker Corp | 1.66% | 2.23% |
| Regeneron Pharmaceuticals Inc | 1.00% | 1.60% |
| Edwards Lifesciences Corp | 0.79% | 1.73% |
| Cencora Inc | 0.79% | 2.07% |
Source: SEC Form N-PORT
VHCIX top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between VHCIX and JDOC?
Which is cheaper, VHCIX or JDOC?
Should I own both VHCIX and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.